Husky clinches order for integrated medical systems in Russia


Canadian machine maker Husky Injection Molding Systems says it has clinched a strategic win with Pascal Medical that has purchased and installed 12 Husky systems for the manufacture of sterile, disposable medical products.

Committed to becoming a leading player in the Russian market, Pascal Medical has been working in close partnership with Husky to set up its facility in Dubna, Russia, with the goal of replacing foreign-import medical products with premium quality domestic production. Currently focused on disposable syringes, the company plans to expand its product range in the future to include prefilled syringes, infusion and transfusion systems, catheters, vacuum blood collection systems, and parts for epidural anesthesia.

Husky has been involved in all aspects of the project, including the planning for a 10,000 sq m factory, syringe design development, and selection of assembling machines, clean room suppliers and even personnel. With its medical tooling branded under the Schöttli banner, Husky says it is able to provide comprehensive, integrated system solutions for the manufacture of medical disposables.

“We are thrilled to be working so closely with Pascal Medical as they complete the first stage of their project, and we look forward to continuing our partnership as they expand production lines and the range of injection molded products they offer,” said Robert Domodossola, Husky’s President of Medical and Specialty Packaging. “As was the case for beverage packaging in Russia 20 years ago, currently there is very little local production of medical disposables.”

The Dubna facility opened and began production recently. Pascal says it is looking at complete production cycles using premium equipment suppliers with the most advanced engineering technology in order to ensure strict compliance with both Russian and international quality standards.

“Our aim at Pascal Medical is to become a world-class supplier, producing the highest quality plastic medical applications. We started construction on our state-of-the-art facility in July of 2016, and today the plant is open and fully operational. The expertise that Husky brings to the table in this industry is extremely valuable to us.”


Copyright (c) 2017 www.injectionmouldingasia.com. All rights reserved.